Singapore markets open in 7 hours 9 minutes

Takeda Pharmaceutical Company Limited (TKPHF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
27.20+0.03 (+0.11%)
As of 09:30AM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
4,154,414,000
4,027,478,000
3,569,006,000
3,197,812,000
3,291,188,000
Cost of revenue
1,310,441,000
1,244,072,000
1,106,846,000
994,308,000
1,089,764,000
Gross profit
2,843,973,000
2,783,406,000
2,462,160,000
2,203,504,000
2,201,424,000
Operating expenses
Research development
682,260,000
633,325,000
526,087,000
455,833,000
492,381,000
Selling general and administrative
1,018,160,000
997,309,000
886,361,000
875,663,000
964,737,000
Total operating expenses
2,528,425,000
2,292,900,000
2,001,315,000
1,694,235,000
2,101,016,000
Operating income or loss
315,548,000
490,506,000
460,845,000
509,269,000
100,408,000
Interest expense
113,796,000
169,698,000
166,607,000
248,631,000
165,006,000
Total other income/expenses net
62,433,000
-8,630,000
-15,367,000
76,000
-23,987,000
Income before tax
194,121,000
375,090,000
302,571,000
366,235,000
-60,754,000
Income tax expense
2,401,000
58,052,000
72,405,000
-9,936,000
-105,044,000
Income from continuing operations
191,720,000
317,038,000
230,166,000
376,171,000
44,290,000
Net income
191,626,000
317,017,000
230,059,000
376,005,000
44,241,000
Net income available to common shareholders
191,626,000
317,017,000
230,059,000
376,005,000
44,241,000
Basic EPS
123.18
204.29
147.14
240.72
28.41
Diluted EPS
121.35
201.94
145.87
238.96
28.25
Basic average shares
1,557,376
1,551,809
1,563,501
1,562,006
1,557,204
Diluted average shares
1,576,431
1,569,872
1,577,169
1,573,537
1,566,204